Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone 15 mg versus 30 mg initial dose for subacute thyroiditis
ChiCTR1900023884Phase 4Not yet recruiting
- Sponsor
- Xiangyang Central Hospital
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of prednisolone in nonsuppurative thyroiditis (2 arms), sponsored by Xiangyang Central Hospital. Primary endpoint: Time required for prednisolone treatment. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
prednisolone
03
Conditions
nonsuppurative thyroiditis
Beyond the preview
Go deeper on ChiCTR1900023884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023884.